Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate.

Ntziachristos V, Schellenberger EA, Ripoll J, Yessayan D, Graves E, Bogdanov A Jr, Josephson L, Weissleder R.

Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12294-9. Epub 2004 Aug 10.

2.

Quantitative analysis of chemotherapeutic effects in tumors using in vivo staining and correlative histology.

Choi HK, Yessayan D, Choi HJ, Schellenberger E, Bogdanov A, Josephson L, Weissleder R, Ntziachristos V.

Cell Oncol. 2005;27(3):183-90.

3.

Near-infrared fluorescent imaging of tumor apoptosis.

Petrovsky A, Schellenberger E, Josephson L, Weissleder R, Bogdanov A Jr.

Cancer Res. 2003 Apr 15;63(8):1936-42.

4.

Validation of in vivo fluorochrome concentrations measured using fluorescence molecular tomography.

Graves EE, Yessayan D, Turner G, Weissleder R, Ntziachristos V.

J Biomed Opt. 2005 Jul-Aug;10(4):44019.

PMID:
16178652
5.

Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy.

Schellenberger EA, Bogdanov A Jr, Petrovsky A, Ntziachristos V, Weissleder R, Josephson L.

Neoplasia. 2003 May-Jun;5(3):187-92. doi: 10.1016/S1476-5586(03)80050-7.

6.

Tomographic fluorescence imaging of tumor vascular volume in mice.

Montet X, Figueiredo JL, Alencar H, Ntziachristos V, Mahmood U, Weissleder R.

Radiology. 2007 Mar;242(3):751-8.

PMID:
17325064
7.

Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.

Qi S, Miao Z, Liu H, Xu Y, Feng Y, Cheng Z.

Bioconjug Chem. 2012 Jun 20;23(6):1149-56. doi: 10.1021/bc200596a. Epub 2012 Jun 4.

PMID:
22621238
8.

Absorption reconstruction improves biodistribution assessment of fluorescent nanoprobes using hybrid fluorescence-mediated tomography.

Gremse F, Theek B, Kunjachan S, Lederle W, Pardo A, Barth S, Lammers T, Naumann U, Kiessling F.

Theranostics. 2014 Jul 26;4(10):960-71. doi: 10.7150/thno.9293. eCollection 2014.

9.

Joint L1 and total variation regularization for fluorescence molecular tomography.

Dutta J, Ahn S, Li C, Cherry SR, Leahy RM.

Phys Med Biol. 2012 Mar 21;57(6):1459-76. doi: 10.1088/0031-9155/57/6/1459. Epub 2012 Mar 5.

10.

Fluorescence molecular imaging of small animal tumor models.

Graves EE, Weissleder R, Ntziachristos V.

Curr Mol Med. 2004 Jun;4(4):419-30. Review.

PMID:
15354872
11.

Sensitivity of molecular target detection by multispectral optoacoustic tomography (MSOT).

Razansky D, Baeten J, Ntziachristos V.

Med Phys. 2009 Mar;36(3):939-45.

PMID:
19378754
12.

Visualization of pulmonary inflammation using noninvasive fluorescence molecular imaging.

Haller J, Hyde D, Deliolanis N, de Kleine R, Niedre M, Ntziachristos V.

J Appl Physiol (1985). 2008 Mar;104(3):795-802. doi: 10.1152/japplphysiol.00959.2007. Epub 2008 Jan 17.

13.

Fluorescence molecular tomography of an animal model using structured light rotating view acquisition.

Ducros N, Bassi A, Valentini G, Canti G, Arridge S, D'Andrea C.

J Biomed Opt. 2013 Feb;18(2):20503. doi: 10.1117/1.JBO.18.2.020503.

PMID:
23344841
14.

Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice.

Cheng Z, Levi J, Xiong Z, Gheysens O, Keren S, Chen X, Gambhir SS.

Bioconjug Chem. 2006 May-Jun;17(3):662-9.

15.

In vivo optical imaging of human lymphoma xenograft using a library-derived peptidomimetic against alpha4beta1 integrin.

Peng L, Liu R, Andrei M, Xiao W, Lam KS.

Mol Cancer Ther. 2008 Feb;7(2):432-7. doi: 10.1158/1535-7163.MCT-07-0575. Epub 2008 Feb 1.

16.

Fluorescence tomographic imaging using a handheld-probe-based optical imager: extensive phantom studies.

Ge J, Erickson SJ, Godavarty A.

Appl Opt. 2009 Nov 20;48(33):6408-16. doi: 10.1364/AO.48.006408.

17.

A modularly designed fluorescence molecular tomography system for multi-modality imaging.

Wang G, Zhang B, Ding Y, He Y, Chen J, Lu Y, Jiang X, Shi J, Bai J, Ren Q, Li C.

J Xray Sci Technol. 2015;23(2):147-56. doi: 10.3233/XST-150478.

PMID:
25882728
18.

Early photon tomography allows fluorescence detection of lung carcinomas and disease progression in mice in vivo.

Niedre MJ, de Kleine RH, Aikawa E, Kirsch DG, Weissleder R, Ntziachristos V.

Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19126-31. doi: 10.1073/pnas.0804798105. Epub 2008 Nov 17.

19.

Excitation spectroscopy in multispectral optical fluorescence tomography: methodology, feasibility and computer simulation studies.

Chaudhari AJ, Ahn S, Levenson R, Badawi RD, Cherry SR, Leahy RM.

Phys Med Biol. 2009 Aug 7;54(15):4687-704. doi: 10.1088/0031-9155/54/15/004. Epub 2009 Jul 10.

20.

Fluorescence background subtraction technique for hybrid fluorescence molecular tomography/x-ray computed tomography imaging of a mouse model of early stage lung cancer.

Ale A, Ermolayev V, Deliolanis NC, Ntziachristos V.

J Biomed Opt. 2013 May;18(5):56006. doi: 10.1117/1.JBO.18.5.056006.

PMID:
23640077

Supplemental Content

Support Center